M. Watabe et al., Preparation, Pt-195 NMR spectra and biological activity of platinum(IV) complexes with dipeptides, J INORG BIO, 73(1-2), 1999, pp. 1-5
Three dipeptide complexes of the form K[Pt(IV) (dipep)Cl(OH)(2)] and four d
ipeptide complexes of the form K[Pt(IV)-(Hdipep)Cl-2(OH)(2)] were newly pre
pared. The Pt-195 NMR peaks of the K[Pt(IV) (dipep)Cl(OH)(2)] complexes app
eared at about 1200 ppm and these chemical shifts were about 3150 ppm downf
ield compared with those of the K [Pt(II) (dipep) Cl] complexes. The chemic
al shifts of the K[Pt(TV)(Hdipep)Cl-2(OH)(2)] complexes were at about 900 p
pm, i.e., about 3050 ppm downfield compared with those of the K[Pt(II) (Hdi
pep) Cl] complexes. The H[Pt(IV) (Hdigly) Cl-2(OH)(2)] and K[Pt(TV) (Hdigly
) Cl-2(OH)Cl] complexes inhibited the growth of C. albicans at a more dilut
ed concentration than cisplatin at 1 mu g/ml, but the platinum complexes on
ly weakly inhibited the growth of these cells compared with the cisplatin-i
nhibited growth of Meth-A and Hep-2 cells at 10 mu g/ml. These results sugg
ested that the platinum complexes selectively inhibited the growth of funga
l cells. (C) 1999 Elsevier Science Inc. All rights reserved.